Stay updated on Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.

Latest updates to the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page
- Check6 days agoChange Detected- Added a new Study Status entry in the record history (version 37, dated 2026-01-30). - Deleted the 2025-10-29 entry from the history.SummaryDifference0.3%

- Check13 days agoChange DetectedNew site revision v3.4.2 was added and the previous revision v3.4.1 was removed; this is a routine version update with no impact on study records or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. The change involves only the version label and does not alter study records or page content.SummaryDifference0.1%

- Check27 days agoChange DetectedGlossary toggle is now visible, and the history uses green highlights for additions and red highlights for deletions with explanatory color coding. The revision label updated to v3.4.0 (from v3.3.4).SummaryDifference0.7%

- Check42 days agoChange DetectedA new Revision: v3.3.4 was added to the Record History and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedLatest history entry shows Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed from the footer.SummaryDifference0.1%

Stay in the know with updates to Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.